Cellex Cell Professionals GmbH

Cellex Cell Professionals is a Germany-based contract development and manufacturing organization (CDMO) with over 10 years of experience in autologous and allogeneic cell and gene therapy (CGT) products. The company supports partners from preclinical development through to commercialization and is involved in the manufacturing of several commercial CAR-T therapies. Its services include cell collection, supply chain management, logistics, and consulting on GMP processes. Cellex was a founding partner in the 2021 launch of AvenCell Therapeutics, a CAR T-cell therapy company, to which it contributed its switchable universal CAR-T technology and manufacturing expertise.